Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 1
1968 2
1969 1
1970 3
1971 4
1972 11
1973 6
1974 5
1975 14
1976 22
1977 17
1978 26
1979 22
1980 30
1981 29
1982 19
1983 25
1984 18
1985 18
1986 18
1987 28
1988 21
1989 36
1990 18
1991 35
1992 18
1993 32
1994 26
1995 29
1996 31
1997 38
1998 27
1999 37
2000 46
2001 44
2002 36
2003 42
2004 45
2005 52
2006 51
2007 62
2008 60
2009 76
2010 88
2011 136
2012 157
2013 206
2014 198
2015 235
2016 287
2017 334
2018 340
2019 415
2020 478
2021 500
2022 508
2023 503
2024 259

Text availability

Article attribute

Article type

Publication date

Search Results

5,069 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Tranexamic acid: a clinical review.
Ng W, Jerath A, Wąsowicz M. Ng W, et al. Anaesthesiol Intensive Ther. 2015;47(4):339-50. doi: 10.5603/AIT.a2015.0011. Epub 2015 Mar 23. Anaesthesiol Intensive Ther. 2015. PMID: 25797505 Free article. Review.
Blood loss and subsequent transfusions are associated with major morbidity and mortality. The use of antifibrinolytics can reduce blood loss in cardiac surgery, trauma, orthopedic surgery, liver surgery and solid organ transplantation, obstetrics and g …
Blood loss and subsequent transfusions are associated with major morbidity and mortality. The use of antifibrinolytics can red …
Clinical use of tranexamic acid: evidences and controversies.
Colomina MJ, Contreras L, Guilabert P, Koo M, M Ndez E, Sabate A. Colomina MJ, et al. Braz J Anesthesiol. 2022 Nov-Dec;72(6):795-812. doi: 10.1016/j.bjane.2021.08.022. Epub 2021 Oct 7. Braz J Anesthesiol. 2022. PMID: 34626756 Free PMC article. Review.
Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. ...Severe events are rare in clinical trials, and literature …
Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and …
Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Wand O, et al. Chest. 2018 Dec;154(6):1379-1384. doi: 10.1016/j.chest.2018.09.026. Epub 2018 Oct 12. Chest. 2018. PMID: 30321510 Clinical Trial.
BACKGROUND: Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to control bleeding. To date, there have been no prospective studies of the effectiveness of inhaled TA for the treatment of hemoptysis. ...
BACKGROUND: Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to control bleeding. To date, there h …
Tranexamic acid: Beyond antifibrinolysis.
Prudovsky I, Kacer D, Zucco VV, Palmeri M, Falank C, Kramer R, Carter D, Rappold J. Prudovsky I, et al. Transfusion. 2022 Aug;62 Suppl 1:S301-S312. doi: 10.1111/trf.16976. Epub 2022 Jul 14. Transfusion. 2022. PMID: 35834488 Review.
Tranexamic acid (TXA) is a popular antifibrinolytic drug widely used in hemorrhagic trauma patients and cardiovascular, orthopedic, and gynecological surgical patients. ...Besides preventing fibrinolysis and blood loss, TXA has been reported to …
Tranexamic acid (TXA) is a popular antifibrinolytic drug widely used in hemorrhagic trauma patients and cardiovascular, orthop …
Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials.
Lee PL, Yang KS, Tsai HW, Hou SK, Kang YN, Chang CC. Lee PL, et al. Am J Emerg Med. 2021 Jul;45:269-279. doi: 10.1016/j.ajem.2020.08.062. Epub 2020 Aug 29. Am J Emerg Med. 2021. PMID: 33041136
BACKGROUND: Acute gastrointestinal bleeding is a common life-threatening emergent condition. Immediate tranexamic acid is useful for reducing hemorrhage following operation and bleeding trauma, but evidence on the effects of tranexamic acid …
BACKGROUND: Acute gastrointestinal bleeding is a common life-threatening emergent condition. Immediate tranexamic acid is usef …
Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S, Ayres E, Bak H, Manco M, Lynch S, Raab S, Du A, Green D, Skobowiat C, Wangari-Talbot J, Zheng Q. Desai S, et al. J Drugs Dermatol. 2019 May 1;18(5):454-459. J Drugs Dermatol. 2019. PMID: 31141852 Clinical Trial.
Topical treatment is challenging, using a range of modalities, to stop, hinder, and/or prevent steps in the pigment production process. Tranexamic acid (TXA), a potent plasmin inhibitor, is proposed to control pigmentation by inhibiting the release of inflammatory m …
Topical treatment is challenging, using a range of modalities, to stop, hinder, and/or prevent steps in the pigment production process. T …
Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial.
DeFrancesco CJ, Reichel JF, Gbaje E, Popovic M, Freeman C, Wong M, DeMeo D, Liu J, Gonzalez Della Valle A, Ranawat A, Cross M, Sculco PK, Haskins S, Kim D, Maalouf D, Kirksey M, Jules-Elysee K, Soffin EM, Kumar K, Beathe J, Figgie M, Inglis A Jr, Garvin S, Alexiades M, DelPizzo K, Russell LA, Sideris A, Saleh J, Zhong H, Memtsoudis SG. DeFrancesco CJ, et al. Br J Anaesth. 2023 Feb;130(2):234-241. doi: 10.1016/j.bja.2022.11.003. Epub 2022 Dec 14. Br J Anaesth. 2023. PMID: 36526484 Free PMC article. Clinical Trial.
BACKGROUND: Tranexamic acid (TXA) reduces rates of blood transfusion for total hip arthroplasty (THA) and total knee arthroplasty (TKA). ...Oral TXA was non-inferior to i.v. TXA in terms of calculated blood loss for both THA (effect size= …
BACKGROUND: Tranexamic acid (TXA) reduces rates of blood transfusion for total hip arthroplasty (THA) and total knee ar …
THE USE OF TRANEXAMIC ACID IN DERMATOLOGY.
Gaćina K, Krstanović Ćosić A. Gaćina K, et al. Acta Clin Croat. 2023 Aug;62(2):368-372. doi: 10.20471/acc.2023.62.02.16. Acta Clin Croat. 2023. PMID: 38549597 Free PMC article. Review.
Tranexamic acid is a synthetic derivative of the amino acid lysine, an antifibrinolytic that is primarily used to reduce bleeding in surgery, trauma, and dental procedures. ...This review article presents evidence for the effectiveness of tra …
Tranexamic acid is a synthetic derivative of the amino acid lysine, an antifibrinolytic that is primarily used to reduc …
Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Bailey AJM, Li HO, Tan MG, Cheng W, Dover JS. Bailey AJM, et al. J Am Acad Dermatol. 2022 Apr;86(4):797-810. doi: 10.1016/j.jaad.2021.03.116. Epub 2021 Apr 12. J Am Acad Dermatol. 2022. PMID: 33857549
OBJECTIVE: To conduct a systematic review and meta-analysis on the efficacy of microneedling as an adjuvant to topical therapies for the treatment of melasma. METHODS: This study followed PRISMA guidelines. All comparative, prospective studies on the use of t …
OBJECTIVE: To conduct a systematic review and meta-analysis on the efficacy of microneedling as an adjuvant to topical therapies for the tre …
Tranexamic Acid: An Evergreen Hemostatic Agent.
Franchini M, Focosi D, Mannucci PM. Franchini M, et al. Semin Thromb Hemost. 2024 Jul;50(5):733-738. doi: 10.1055/s-0044-1779632. Epub 2024 Feb 9. Semin Thromb Hemost. 2024. PMID: 38335995 Review.
Tranexamic acid (TXA) is an important antifibrinolytic agent, which inhibits plasminogen activation and fibrinolysis. Several controlled randomized trials have investigated the role of TXA in preventing or decreasing blood loss across different …
Tranexamic acid (TXA) is an important antifibrinolytic agent, which inhibits plasminogen activation and fibrinolysis. Several …
5,069 results